Primary Prevention of Cancer

Primary Prevention of Cancer Your stories on cancer present well-rounded perspectives on cancer treatment.1,2 However, for targeting cancer incidence and mortalities, increased attention must be directed toward primary prevention of cancer, rather than most resources being centered on molecular and mechanistic biology, diagnoses, and treatment regimens. These issues are vitally important, but primary prevention has been too long proportionately neglected. Except for tobacco, and even there g

Written byJames Huff
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Your stories on cancer present well-rounded perspectives on cancer treatment.1,2 However, for targeting cancer incidence and mortalities, increased attention must be directed toward primary prevention of cancer, rather than most resources being centered on molecular and mechanistic biology, diagnoses, and treatment regimens. These issues are vitally important, but primary prevention has been too long proportionately neglected. Except for tobacco, and even there global public health attention to this disaster is woeful, there are few concerted efforts toward primary prevention of cancer and related diseases.

We endorse eating fruits and vegetables, exercise, physical activity, maintaining healthy body weights, eating suitable diets, avoiding sun exposures/artificial tanning, using screening diagnostic aids judiciously (PSA, mammograms, pap smears), and limiting consumption of alcohol/tobacco. Clearly, more must be done in other aspects of primary prevention: avoiding known/suspected environmental causes of cancers, and identifying additional causes. Too much attention and resources are geared toward molecular carcinogenesis and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies